- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04062968
Video Education for Prenatal Testing Choices
The Effect of Standardized Video Education on Prenatal Genetic Testing Choices, Decisional Conflict, and Decisional Regret
Descripción general del estudio
Descripción detallada
This is a prospective randomized trial of video education on prenatal testing vs. usual care, with the goal to assess women's prenatal testing choices, understanding of testing options and decisional conflict and regret. Participants will be recruited from a convenience sample of patients presenting for prenatal care at Naval Medical Center San Diego (NMCSD).
While receiving prenatal care at NMCSD, all women are offered the option of screening for aneuploidy (serum screen (with or without nuchal translucency ultrasound) or cell free DNA testing) or diagnostic testing (chorionic villous sampling or amniocentesis) or no testing in pregnancy.
After providing consent, participants will be randomized to video education or usual care. Randomization will be completed using a random number table. Women randomized to the intervention group (video education) will view the prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .7 They will then complete the study related surveys at their initial obstetric visit. The educational video was created with input from clinicians including licensed genetic counselors, obstetricians, maternal fetal medicine physicians, and patients. Extensive testing and reviewing was completed to ensure adequate comprehension by a wide range of audiences and minimize counseling bias. Women randomized to the control group will receive routine prenatal care with no additional study intervention other than completion of the study related surveys at baseline (initial prenatal testing). Current national guidelines recommend offering all women prenatal diagnosis and prenatal screening at the beginning of the pregnancy.1
The primary outcome for this study will be screening uptake rates, and will be based on review of the patient's electronic medical record. Secondary outcomes will include invasive diagnostic test rates, participant knowledge about testing (as assessed using the Maternal Serum Screening Knowledge Questionnaire,2 and decisional conflict (as assessed by the Decisional Conflict Scale) and decisional regret (as assessed by the Decision Regret Scale). These assessments will be conducted at time of prenatal testing (< 20 weeks). (Appendix A)
The study questionnaire will include a check box for participants to indicate if they would be willing to participate in a follow on qualitative study to assess participant's personal experience related to their method of education about prenatal testing. This component of the study will aim to determine personal and social reasoning behind their decisions, and to further explore their experience, beliefs and behaviors. Interested participants from each group (both intervention and control) will be contacted to arrange a telephone or in person interview. (Appendix C) Participants will be interviewed in person or over the phone.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
San Diego, California, Estados Unidos, 92134
- Naval Medical Center San Diego
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Greater than or equal to 18 years of age
- Gestational age less than or equal to 20 weeks
- Singleton gestation
- Not completed aneuploidy screening in this pregnancy
- Available to watch the 15 minute video
- Ability to read, write, and understand English
Exclusion Criteria:
- Pregnant women not eligible for care at Military Treatment Facility
- Less than 18 years of age
- Gestational age greater than 20 weeks
- Multiple gestation
- Aneuploidy testing in current pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Video education
Women randomized to the intervention group (video education) will view the prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .7
They will then complete the study related surveys at their initial obstetric visit.
|
Prenatal screening video made by the Genetic Support Foundation and the Washington Department of Health, the 4.5 minute video "How to Decide About Prenatal Genetic Testing," available at: https://www.geneticsupportfoundation.org/genetics-and-you/pregnancy-and-genetics/prenatal-genetic-testing-videos .
|
Sin intervención: Usual care
Women randomized to the control group will receive routine prenatal care with no additional study intervention other than completion of the study related surveys at baseline (initial prenatal testing).
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
screening uptake rates
Periodo de tiempo: 24-36 weeks gestation
|
Genetic screening
|
24-36 weeks gestation
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Invasive diagnostic test rates
Periodo de tiempo: 24-36 weeks gestation
|
Diagnostic testing such as Chorinonic Villus Sampling and amniocentesis
|
24-36 weeks gestation
|
Participant knowledge about prenatal testing
Periodo de tiempo: up to 20 weeks gestation
|
Assessed by using the Maternal Serum Screening knowledge Questionnaire.
Scores range from 0 to 15, reflecting the number of correct answers.
A score of zero would indicate zero correct answers, where a score of 15 would indicate all answers were correct.
Higher scores are considered better outcome indicating higher knowledge.
|
up to 20 weeks gestation
|
Decisional conflict
Periodo de tiempo: up to 20 weeks gestation
|
Assessed by the Decisional Conflict Scale.
Questions are scored on a Likert scale of 1 to 5, with 1 equating to Strongly Agree and 5 equating to Strongly Disagree.
Thus, lower scores indicate lower decisional conflict.
Subscale Decisional Uncertainty score range 3 to 15. Subscale Percieved Effective Decision range 4 to 20.
|
up to 20 weeks gestation
|
Decisonal regret
Periodo de tiempo: up to 20 weeks gestation
|
Assessed by the Decisional Regret Scale.
Questions are scored on a Likert scale of 1 to 5, with 1 equating to Strongly Agree and 5 equating to Strongly Disagree.
Thus, lower scores indicate lower decisional regret.
Decisional Regret scores range 0 to 100.
|
up to 20 weeks gestation
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- NMCSD.2016.0070
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Video education
-
Medical College of WisconsinActivo, no reclutando
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of MelbourneActivo, no reclutandoDesarrollo del lenguajeReino Unido
-
Stanford UniversityTerminadoTrastorno autistaEstados Unidos
-
Dartmouth-Hitchcock Medical CenterReclutamientoCongelación | Congelación de la mano | Congelación de pieEstados Unidos
-
Dartmouth-Hitchcock Medical CenterTerminadoCongelación | Congelación de la mano | Congelación de pieEstados Unidos
-
University of MichiganReuben Phoenix Schostak Fontan Wellness Project FundReclutamientoFragilidad | Fisiología de Fontan | Enfermedad cardíaca de ventrículo únicoEstados Unidos
-
Stanford UniversityNational Institute on Aging (NIA)ReclutamientoLa inactividad físicaEstados Unidos
-
Duke UniversityTerminadoTratamiento y prevención de la anemia después de la administración de la barra nutricional GudnessIndia
-
University of Texas Southwestern Medical CenterAmerican Heart AssociationAún no reclutandoInsuficiencia Cardíaca Sistólica
-
Washington University School of MedicineTerminadoCáncer | Trastorno geriátrico | Caída del pacienteEstados Unidos